David Wu
Independent Director at Seraphina Therapeutics
San Francisco Bay Area
Overview
Work Experience
Venture Partner
2022 - Current
General Partner
2012 - 2022
Independent Director
2024
Manufacturer of Fatty15, the world’s first, and only science-backed, patented, award-winning C15:0 supplement that supports your long-term health & wellness.
Seraphina Therapeutics provides therapeutics services using natural products.
Raised $5,500,000.00 from Domain Associates and Murano Group.
Independent Director
2024
Compensation Committee.
Member, Board of Directors
2022
Nominations & governance committee, finance committee, audit committee, marketing committee, and GRAMMY Blue Ribbon Adjudication Committee.
Member, Board of Directors
2020
Compensation committee.
Member, Board of Directors
2018
Illumix is an infrastructure solution that develops augmented reality games.
Raised $26,600,000.00 from Henry Kravis, Matthew Ball, Xavier Niel, Sony Innovation Fund, RW3 Ventures, Visible Ventures, OpenView, Mark Cuban and LightShed Ventures.
Member, Board of Directors
2016
Audit committee.
Booster is a fleet management company that specializes in delivering renewable fuels, gasoline, diesel, and bio-diesel delivery services.
Raised $213,612,016.00 from Madrona, Conversion Capital, Thayer Ventures, Cercano Management, Chaac Ventures, Mitsubishi Corporation, Invus Opportunities, Version One Ventures, Renewable Energy Group and Equinor Ventures.
Independent Director
2013 - 2024
Eargo went public (NASDAQ: EAR) in 2020. Audit committee chair, compensation committee, and special committee.
Eargo specializes in the design and development of hearing aids.
Raised $371,476,928.00 from Patient Square Capital.
Member, Board of Directors
2021 - 2024
Member, Board Of Directors
2017 - 2022
Inkbox was acquired by BiC in 2022.